Today: 8 July 2026
Browse Category

Stock Market 16 June 2026

SRx Health Solutions gains as EMJX crypto pivot draws traders

SRx Health Solutions gains as EMJX crypto pivot draws traders

SRx Health Solutions Inc. shares surged Tuesday, pushing higher as the NYSE American-traded stock kept up its recent volatile run. Investors watched the company’s ongoing move toward EMJ Crypto Technologies and digital-asset treasury management. SRXH closed at roughly $0.19, up 21% at 4 p.m. in New York, according to Google Finance. Volume came in at 176.3 million shares, well above the average of 46.2 million. SRx is seeing its trading pattern shift. It’s no longer acting as a typical small pet-health stock, but instead is behaving like a stand-in for a planned crypto-treasury platform. That means the corporate balance sheet would hold or run cryptocurrencies and digital assets, as opposed to sticking with cash and short-term investments.
16 June 2026
··
Rocket Companies steady at $14 as BTIG downgrades, firm refinances debt

Rocket Companies steady at $14 as BTIG downgrades, firm refinances debt

Rocket Companies was steady late Tuesday, sticking close to $14. BTIG cut its rating on the mortgage lender, while traders watched for a debt refinancing set to finish the same day. Shares last changed hands at $13.93, up 0.1%, moving in a range from $13.46 to $14.35 during the day. Rocket is in focus now as a listed housing-finance stock sensitive to moves in mortgage demand. If rates drop, buyers and homeowners have more incentive to take out new loans or refinance. Demand can slow when rates go up or stay elevated.
16 June 2026
·
ARK ramps up SpaceX buys as Musk-led stocks keep rallying

ARK ramps up SpaceX buys as Musk-led stocks keep rallying

ARK Invest has bought a stake in SpaceX valued at over $500 million, one of its largest market moves in years as Elon Musk’s rocket and AI company draws new trading interest. Cathie Wood’s firm picked up almost 3.3 million SpaceX shares on IPO day, according to trade figures reported by CoinDesk. Timing stands out in this trade. SpaceX shares jumped after last week’s debut, fueled by strong demand both for the stock and for options contracts. Those contracts let investors buy or sell shares at specific prices. Reuters said Tuesday that SpaceX overtook Amazon’s market cap and at one point passed Microsoft during the session before pulling back.
16 June 2026
···
Dow Closes Above 52,000; Nasdaq Slides on Tech Retreat After the Bell

Dow Closes Above 52,000; Nasdaq Slides on Tech Retreat After the Bell

Dow edges higher, S&P 500 and Nasdaq drop as rotation hits tech Stocks finished mixed on Wall Street Tuesday. The Dow Jones Industrial Average ended up 0.64% at 52,003.34. The S&P 500 slipped 0.41% to 7,523.07, and the Nasdaq Composite lost 0.86% to close at 26,455.00. Investors rotated out of big tech and chip stocks, putting pressure on the S&P 500 and Nasdaq, while financials and industrials lifted the price-weighted Dow. Higher-priced names pushed the Dow higher as selling hit other parts of the market. Stocks traded mixed as investors took profits after Monday’s jump on hopes for a U.S.-Iran deal and the chance the Strait of Hormuz could reopen. Earlier, Reuters said tech was the biggest drag on the S&P, while banks led the rebound, lifted by JPMorgan Chase, Wells Fargo and Bank of America. “We’re just digesting some of those gains and the setup in anticipation of the Fed meeting is always a little tentative,” Mark Luschini, chief investment strategist at Janney Montgomery Scott, told Reuters.
16 June 2026
····
Dow climbs past 52,000 as banks, industrials help counter tech weakness

Dow climbs past 52,000 as banks, industrials help counter tech weakness

NEW YORK, June 16, 2026, 16:02 EDT. Dow Jones Industrial Average closed at 52,003.34 on Tuesday, gaining 332.31 points, or 0.64%. Investors shifted money into banks, industrials and other blue chips, cutting tech. The climb marked a fresh closing high for the Dow after it touched 52,189.97 during the session, Investing.com historical data show. S&P 500 and Nasdaq lagged near the close, with growth names under pressure but no sign of panic selling.
16 June 2026
·····
Lloyds Gains With FTSE 100 Bank Stocks, LLOY Up After 2026 Climb

Lloyds Gains With FTSE 100 Bank Stocks, LLOY Up After 2026 Climb

London, June 16, 2026, 20:10. Lloyds Banking Group plc shares were higher Tuesday as UK banks moved with the FTSE 100. Lloyds closed near 104p, up by 1.3%–1.4% on the session. The FTSE 100 added 0.61%. MarketWatch said Lloyds settled at £1.04. Hargreaves Lansdown quoted 103.95p/104.05p at the close. Reuters said gains in financials and industrials, with oil weaker, helped the FTSE 100.
16 June 2026
··
AT&T Shares Drift Near 52-Week Low as Debt, Dividend and Earnings Stay in View

AT&T Shares Drift Near 52-Week Low as Debt, Dividend and Earnings Stay in View

AT&T Inc. shares fell Tuesday, last seen at $22.95, off 1.5% after starting the day at $23.32. AT&T moved in a range of $22.95 to $23.41 on volume around 27.9 million shares. Market value sat near $161 billion, based on latest data. Shares edged close to the 52-week low at $22.32 and are still far from the 52-week high of $29.79. The P/E ratio was about 7.7, so investors were paying less than 8 times annual earnings per share. Investors weren’t reacting to new earnings news, but instead to ongoing concerns around rates, debt, and the telecom sector. Reuters said the Dow set a new intraday high on Tuesday with oil prices down. The S&P 500 and Nasdaq moved lower as the market waited on the Federal Reserve’s rate decision. That’s key for AT&T since high-yield telecom stocks like it often compete with bonds for income buyers. If rates stay up, dividend stocks have to show their cash flow is strong enough to take on equity risk.
16 June 2026
··
Outlook Therapeutics Stock Jumps as FDA Accepts Lytenava BLA, July Decision Looms

Outlook Therapeutics Stock Jumps as FDA Accepts Lytenava BLA, July Decision Looms

Outlook Therapeutics, Inc. stock surged Tuesday after the company said the U.S. Food and Drug Administration accepted its resubmitted Biologics License Application, or BLA, for ONS-5010/LYTENAVA as a treatment for wet age-related macular degeneration. A BLA is the FDA application used to seek approval to market a biologic medicine. OTLK traded at $1.51, up about 30.2% from its previous close of $1.16, with intraday volume above 33.7 million shares, according to market data available in afternoon trading. The move was driven by a clearer and faster regulatory timeline. Outlook said the FDA classified the resubmission as a Class 1 review and set a Prescription Drug User Fee Act, or PDUFA, target action date of July 29, 2026. The PDUFA date is the FDA’s goal date to act on an application, not a guarantee of approval. Chief Executive Bob Jahr said the company was “very pleased” that the FDA accepted the application and called it “great news for Outlook and the LYTENAVA™ team, patients and the retina community.”
16 June 2026
··
JPMorgan Shares Up as Dow Sets Record High

JPMorgan Shares Up as Dow Sets Record High

JPMorgan Chase & Co. jumped Tuesday, with its stock helping push the Dow Jones Industrial Average to a new intraday high as traders snapped up cyclical shares. JPM traded around $330.01, up $10.61 from Monday, and earlier traded as high as $331.71. Market data showed the stock up 3.7% earlier, with the S&P 500 financials sector rising 1.6%. Investors dumped tech and moved into banks and industrials, Reuters said. Oil dropped more than 5% after hopes for a U.S.-Iran peace deal calmed worries about inflation and growth, Reuters said. The move was mostly driven by macro factors. Lower oil can help banks, easing inflation pressure and cutting the odds that rates stay high longer. That can support loan demand and credit quality. It can also lift interest in cyclical stocks, a label for companies that usually see earnings swing with the economy.
16 June 2026
·
Lionsgate Stock Surges as Netflix Takeover Talk Puts LION Back in Deal Spotlight

Lionsgate Stock Surges as Netflix Takeover Talk Puts LION Back in Deal Spotlight

Lionsgate Studios Corp. stock rose sharply Tuesday as investors reacted to fresh takeover speculation around the film and television studio. LION recently traded at $16.35, up $1.98, with an intraday range of $14.33 to $16.69 and volume above 11.8 million shares, according to live market data. Investor’s Business Daily reported that Semafor said Netflix is interested in buying Lionsgate and that several media companies are showing interest in the studio. The stock rose because a potential acquisition can create a takeover premium, meaning a buyer may have to offer more than the market price to persuade shareholders to sell. That same logic can pressure the possible buyer’s stock. Netflix shares fell in the same session, with IBD noting investor concern around another large media deal after Netflix lost out on Warner Bros. Discovery to Paramount Skydance earlier this year.
16 June 2026
·
Ford Shares Dip After China Software Rule Adds Fresh Risk

Ford Shares Dip After China Software Rule Adds Fresh Risk

DETROIT, June 16, 2026, 14:09 EDT. Ford Motor Company shares fell Tuesday afternoon, with F down 1.1% at $14.61. The stock moved between $14.54 and $14.83 during the session, slipping but not dropping hard. General Motors shares also dipped, pointing to some pressure on the big carmakers, but Ford faced new headline risk of its own.
16 June 2026
·
MARA Holdings Jumps After Bitcoin Treasury Update Brings Miner Into View

MARA Holdings Jumps After Bitcoin Treasury Update Brings Miner Into View

MARA Holdings traded up Tuesday afternoon, building on Monday’s gains. Investors shrugged off a weaker Bitcoin move and paid more notice to the miner’s Bitcoin reserves. Shares last changed hands at $14.94, rising 2.1% for the day, with volumes topping 26 million. The stock moved in a range from $14.51 to $15.26, Google Finance data showed. MARA beat the Nasdaq, which slipped about 0.5% during the afternoon. No official company statement kicked off the move. Crypto.news, via MEXC, said Tuesday that on-chain tracker Lookonchain spotted a 1,000 Bitcoin buy on FalconX for about $66.7 million at the time. The report also noted MARA hasn’t confirmed the purchase, so it’s still just an on-chain data point, not a filed acquisition. Bitcoin hovered near $66,000 and slipped 1.1% intraday, so MARA’s rise looks less about Bitcoin's small drop and more about MARA-specific headlines and balance sheet bets.
16 June 2026
···
Plug Power Stock Slips After Brief Bounce as Investors Watch June Cash Test

Plug Power Stock Slips After Brief Bounce as Investors Watch June Cash Test

Plug Power Inc. shares gave back part of Monday’s rebound on Tuesday, trading recently at $2.75, down 1.8%, after moving between $2.70 and $2.88 intraday. The stock’s market value was about $3.82 billion, while its negative earnings per share and negative price-to-earnings ratio — a valuation measure comparing share price with profit per share — underline that investors are still valuing the company on turnaround potential rather than current profits. The pullback followed a modest relief rally. Plug rose 1.45% Monday to close at $2.80, snapping an eight-session losing streak, but that move still lagged a stronger Nasdaq Composite advance of 3.07%. Volume was also light versus recent norms, which made the bounce look more like a pause in selling than a clear change in trend.
16 June 2026
··
Moderna Rises After FDA Review Renews Optimism on mRNA Flu Shot

Moderna Rises After FDA Review Renews Optimism on mRNA Flu Shot

Moderna, Inc. shares jumped Tuesday after FDA staff reviewers said data on the company’s mFlusiva flu shot “may support effectiveness” in adults 65 and up. Moderna traded at $57.19, up about 9.7%. The stock hit an intraday high of $57.36 on nearly 6.8 million shares traded. SPDR S&P 500 ETF Trust slipped 0.4%, with Invesco QQQ Trust down 1.4%. Moderna shares jumped after investors took the FDA review to mean a lower regulatory risk for the vaccine maker’s push into respiratory vaccines outside COVID. FDA staff said immune-response data may back mFlusiva in older adults, Reuters reported. The shot also showed better relative vaccine efficacy than a standard-dose flu shot in people aged 50-64. Relative vaccine efficacy, or rVE, shows how much better one vaccine works over another in a head-to-head trial. In briefing documents, Moderna’s mRNA-1010 posted a 26.6% rVE against RT-PCR-confirmed flu-like symptoms versus standard-dose in people over 50.
16 June 2026
·
Obai debt swap, city deal push Our Bond stock higher in active trade

Obai debt swap, city deal push Our Bond stock higher in active trade

Shares of Our Bond, Inc. jumped Tuesday, with OBAI trading as high as $1.27 and most recently quoted at $0.9911, up roughly 85% from Monday’s $0.5346 close. More than 403 million shares changed hands as traders responded to news of a fresh balance-sheet restructuring and a municipality-backed rollout of the company’s AI security platform. Investors focused on these company updates, looking past the broader market and betting on better liquidity and growth prospects. Our Bond said Ascent Partners Fund LLC will swap around $3.3 million of promissory notes for Series G convertible preferred stock. Convertible preferred is senior to common and can be converted into common shares, which can dilute existing holders. The set conversion price is $2.0265 per share, more than 200% higher than where the stock has traded recently, according to the company. The notes are to be marked paid in full on closing. In a separate SEC filing, Our Bond said the preferred pays a 10% annual dividend, has a 9.99% beneficial ownership cap, and includes redemption and anti-dilution protections.
16 June 2026
·
Lumentum Drops While AI Optics Names Test Highs

Lumentum Drops While AI Optics Names Test Highs

New York, June 16, 2026, 13:10 EDT. Lumentum stock is lower as shares pull back from levels hit in the recent AI optics rally. Peers are facing valuation questions as the group gives up some gains. Lumentum Holdings Inc. shares dropped 7.27% to $887.68 as of 1:07 p.m. EDT on Tuesday, losing some ground after a strong run in AI-infrastructure names. The stock traded between $863.41 and $961.68 earlier in the day, Google Finance data showed. The slide didn’t appear tied to fresh company news, but came after the stock posted a 16.5% gain over the past week, according to Simply Wall St.
16 June 2026
··
Groupe Dynamite Drops as GRGD Investors Look Past 37% Jump in Revenue

Groupe Dynamite Drops as GRGD Investors Look Past 37% Jump in Revenue

Groupe Dynamite Inc. shares plunged Tuesday, down 33.06% to CA$49.83 by 12:53 p.m. EDT, even as the Montreal retailer posted a much stronger first quarter. The TSX-listed name, ticker GRGD, hit a session low of CA$48.33 earlier. Google Finance was showing a market cap of CA$5.65 billion at that price, with a price-to-earnings ratio of 22.62. P/E shows how much investors pay per dollar of profit. Groupe Dynamite posted a strong quarter. The company reported revenue up 37.0% to CA$310.6 million for the 13 weeks ended May 2. Comparable store sales climbed 22.6%. Gross margin hit 67.4%, up 530 basis points. Adjusted EBITDA increased 71.3% to CA$114.4 million. CEO and board chair Andrew Lutfy said the quarter showed the “strength of our operating model.” President and COO Stacie Beaver said, “Q1 was a strong start to fiscal 2026.”
16 June 2026
·
Micron Drops From Highs With AI Tailwind Facing Earnings Bar

Micron Drops From Highs With AI Tailwind Facing Earnings Bar

Micron Technology shares slid Tuesday after hitting a record high, as traders cashed in gains from the stock’s recent AI-fueled run. Shares were last at $1,048.87, off $39.12 from the previous close. The stock opened at $1,100 and moved between $1,020.20 and $1,133.00. This follows Monday’s rally, when Micron closed at a record $1,087.99 after buyers pushed memory-chip stocks higher on hopes for more AI data-center demand. Chip stocks cooled off, with the PHLX Semiconductor Index, or SOX, falling 3.2% at midday Tuesday. The index had been down as much as 4.5% earlier. That’s a problem for Micron, which is seen as a riskier AI infrastructure play. The stock tends to swing hard with semiconductor sentiment, whether or not there’s news from the company itself.
16 June 2026
····
Eos Energy shares jump as battery factory Line 2 goes live

Eos Energy shares jump as battery factory Line 2 goes live

Eos Energy Enterprises, Inc. jumped on Tuesday after saying it started commercial production at its Thorn Hill plant in Marshall Township, Pennsylvania. The company said it completed Site Acceptance Testing for Battery Line 2, meaning they checked the equipment on site before using it in full production. Shares pushed up as much as 13% after the update, trading recently near $7.08, off a high of $7.53 earlier in the day, according to independent market coverage. Eos shares are up as scaling production is key to its investment case. Eos makes zinc-based long-duration energy storage systems, or LDES, which can hold power for hours and release it to grids, data centers or industrial customers when needed. The company said Line 1 output in the first 164 days of 2026 already topped all of what it made in 2025. Eos plans to ramp up Line 2 this year, with subassemblies hitting early Q3 and full production eyed for Q4. “Battery Line 2 demonstrates our ability to continuously improve as we scale,” chief operating officer John Mahaz said.
16 June 2026
··
Gildan Activewear Drops After Short Seller Flags Sales Concerns

Gildan Activewear Drops After Short Seller Flags Sales Concerns

Gildan Activewear Inc. shares sank Tuesday after Jehoshaphat Research revealed a short position and accused the clothing maker of inflating revenue with channel stuffing. Short sellers bet on a stock’s decline, and channel stuffing means sending more goods to distributors or customers than end demand supports. Gildan’s shares on the NYSE were last down 21.7% at $48.50, dropping as low as $46.56 in heavy trading. MarketScreener data showed the stock on the TSX off about 20% to CA$68.96. S&P/TSX Composite edged up, closing in on a record, as risk appetite picked up, according to a Reuters piece on MarketScreener. Gildan shares dropped after Jehoshaphat said it was short the name. The report raises questions around the quality of Gildan’s sales, not just short-term sentiment. When revenue numbers face doubt, investors tend to mark down the earnings multiple and look for stronger proof of cash flow.
16 June 2026
··
1 … 65 66 67 68 69 … 1,628

Stock Market Today

  • Bank of England Looks to Loosen Leverage Rules, Bringing UK Closer to Global Peers
    July 8, 2026, 1:06 AM EDT. The Bank of England is moving to ease leverage ratio rules, saying it wants UK banking regs to match up better with the rest of the world. The FPC said it will boost how banks can use capital buffers, giving lenders more room to dip into these reserves without cutting shareholder payouts. The decision mirrors U.S. steps to relax leverage requirements. The FPC estimates major British banks could see their leverage demands fall by 0.2 percentage points. Some FPC members flagged risks that a looser stance could drive up market-based leverage and hurt UK market strength. The Association for Financial Markets in Europe supported the changes, arguing current UK rules are stricter than global rivals.
Go toTop